As of Nov 19, 2026, 1 of 1 active firms rate DRD a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
DRD EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 0 analysts
Next period, 0 analysts expect DRDGOLD Limited ADR to earn $0.00 a share (range $0.00 – $0.00), versus — a year earlier. Full-year consensus is $2.73.
REVENUE · NEXT QUARTER
—
Range — – — · 0 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $709.0M, rising to $840.0M next year.
Top analysts covering DRDGOLD Limited ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DRD.
#1
Heiko F. Ihle
HC Wainwright & Co. · Rank #46
Buy
$35.00+67.4% to target
Overall win rate
43%
+ Follow
DRD stock forecast FAQ
What is DRD's average 12-month price target?+
The 1 active firms with a live target average $35.00 for DRDGOLD Limited ADR over the next 12 months, ranging from a $35.00 high to a $35.00 low, as of Nov 19, 2026.
Is DRD stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover DRD?+
1 active firms have a recognized rating on DRDGOLD Limited ADR as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering DRD?+
Among analysts who currently cover DRD, Heiko F. Ihle of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #46). Their current call is Buy with a $35.00 target.
What is DRDGOLD Limited ADR's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 0 analysts. Full-year EPS is projected at $2.73, rising to — the following year.
How much revenue is DRDGOLD Limited ADR expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $709.0M, growing to $840.0M next year.
Have analysts been upgrading or downgrading DRD lately?+
As of Nov 19, 2026, 1 of 1 active firms rate DRD a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DRD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.